St Jude Medical Inc. (STJ): Today's Featured Health Services Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

St Jude Medical ( STJ) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 0.8%. By the end of trading, St Jude Medical rose $1.02 (1.8%) to $59.03 on light volume. Throughout the day, 1,342,917 shares of St Jude Medical exchanged hands as compared to its average daily volume of 1,923,000 shares. The stock ranged in a price between $57.96-$59.29 after having opened the day at $57.96 as compared to the previous trading day's close of $58.01. Other companies within the Health Services industry that increased today were: BioScrip ( BIOS), up 17.3%, LipoScience ( LPDX), up 14.8%, InspireMD ( NSPR), up 9.0% and Unilife Corporation ( UNIS), up 8.9%.

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in two divisions, Cardiovascular and Ablation Technologies, and Implantable Electronic Systems. St Jude Medical has a market cap of $17.1 billion and is part of the health care sector. The company has a P/E ratio of 23.7, above the S&P 500 P/E ratio of 17.7. Shares are up 61.7% year to date as of the close of trading on Tuesday. Currently there are 10 analysts that rate St Jude Medical a buy, 1 analyst rates it a sell, and 10 rate it a hold.

TheStreet Ratings rates St Jude Medical as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, notable return on equity, increase in net income and growth in earnings per share. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the negative front, Bio-Reference Labs ( BRLI), down 21.7%, ERBA Diagnostics ( ERB), down 7.7%, Organovo Holdings ( ONVO), down 3.9% and Baxano Surgical ( BAXS), down 2.9% , were all laggards within the health services industry with Quest Diagnostics ( DGX) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.
null

If you liked this article you might like

Can Abbott Outperform Despite Alere?

Can Abbott Outperform Despite Alere?

Abbott Shares Dip on Mixed Fourth-Quarter Earnings

Abbott Shares Dip on Mixed Fourth-Quarter Earnings

Abbott Labs: Diagnosing Growth in 2017

Abbott Labs: Diagnosing Growth in 2017

Abbott Laboratories Can Merge With St. Jude Medical: FTC

Abbott Laboratories Can Merge With St. Jude Medical: FTC

FTC Allows Abbott to Spin Off Units, Buy St. Jude Medical

FTC Allows Abbott to Spin Off Units, Buy St. Jude Medical